The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21
Open accessAbstract
SUMMARY PARP inhibitors (PARPi) prevent cancer cell growth by inducing synthetic lethality with DNA repair defects (e.g., in BRCA1/2 mutant cells). We have identified an alternate pathway for PARPi-mediated growth control in BRCA1/2-intact breast cancer cells involving rDNA transcription and ribosome biogenesis. PARP-1 binds to snoRNAs, which stimulate PARP-1 catalytic activity in the nucleolus independent of DNA damage. Activated PARP-1 ADP-ribosylates DDX21, an RNA helicase that localizes to nucleoli and promotes rDNA transcription when ADP-ribosylated. Treatment with PARPi or mutation of the ADP-ribosylation sites reduce DDX21 nucleolar localization, rDNA transcription, ribosome biogenesis, protein translation, and cell growth. The salient features of this pathway are evident in xenografts in mice and human breast cancer patient samples. Elevated levels of PARP-1 and nucleolar DDX21 are associated with cancer-related outcomes. Our studies provide a mechanistic rationale for efficacy of PARPi in cancer cells lacking defects in DNA repair whose growth is inhibited by PARPi.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398
psych: Procedures for Personality and Psychological Research
Revelle, W. (2017) · Cited by 3,321
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mirza, M. R., Monk, B. J., Herrstedt, J., Oza, A. M., Mahner, S., Redondo, A., Fabbro, M., Ledermann, J. A., Lorusso, D., Vergote, I., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611310 · Cited by 2,451
Normalization of RNA-seq data using factor analysis of control genes or samples
Risso, D., Ngai, J., Speed, T. P., & Dudoit, S. (2014) · Nature Biotechnology · doi:10.1038/nbt.2931 · Cited by 2,052
SUnSET, a nonradioactive method to monitor protein synthesis
Schmidt, E. K., Clavarino, G., Ceppi, M., & Pierre, P. (2009) · Nature Methods · doi:10.1038/nmeth.1314 · Cited by 1,706
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70228-1 · Cited by 1,442
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226
Self-citationGenome-wide Identification of Polycomb-Associated RNAs by RIP-seq
Zhao, J., Ohsumi, T. K., Kung, J. T., Ogawa, Y., Grau, D. J., Sarma, K., Song, J. J., Kingston, R. E., Borowsky, M., & Lee, J. T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.12.011 · Cited by 977
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical Targets
Krishnakumar, R., & Kraus, W. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.017 · Cited by 836
Self-citationPARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways
Wang, M., Wu, W., Wu, W., Rosidi, B., Zhang, L., Wang, H., & Iliakis, G. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl840 · Cited by 820
Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Self-citationPARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681 · cited 2×
“Upon activation, PARP-1 uses nicotinamide adenine dinucleotide (NAD+) to catalyze the addition of poly(ADP-ribose) (PAR) polymers on target proteins (Gupte et al., 2017; Ryu et al., 2015).”
BackgroundSelf-citationAnticancer Activity of CX-3543: A Direct Inhibitor of rRNA Biogenesis
Drygin, D., Siddiqui-Jain, A., O'Brien, S., Schwaebe, M., Lin, A., Bliesath, J., Ho, C. B., Proffitt, C., Trent, K., Whitten, J. P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1304 · Cited by 588
Kim, M. Y., Mauro, S., Gévry, N., Lis, J. T., & Kraus, W. L. (2004) · Cell · doi:10.1016/j.cell.2004.11.002 · Cited by 550
Self-citationKraus, W. L., & Lis, J. T. (2003) · Cell · doi:10.1016/s0092-8674(03)00433-1 · Cited by 546
Self-citationLNCipedia: a database for annotated human lncRNA transcript sequences and structures
Volders, P.-J., Helsens, K., Wang, X., Menten, B., Martens, L., Gevaert, K., Vandesompele, J., & Mestdagh, P. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks915 · Cited by 523
High speed of fork progression induces DNA replication stress and genomic instability
Maya-Mendoza, A., Moudry, P., Merchut-Maya, J. M., Lee, M., Strauss, R., & Bartek, J. (2018) · Nature · doi:10.1038/s41586-018-0261-5 · Cited by 514 · cited 1×
“Recent studies have also suggested that PARP inhibition may induce replication stress and subsequent DNA damage (Hanzlikova et al., 2018; Maya-Mendoza et al., 2018; Parsels et al., 2018).”
BackgroundWatkins, N. J., & Bohnsack, M. T. (2012) · WIREs RNA · doi:10.1002/wrna.117 · Cited by 483
Function and synthesis of small nucleolar RNAs
Tollervey, D., & Kiss, T. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80005-1 · Cited by 467
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
Ringnér, M., Fredlund, E., Häkkinen, J., Borg, Å., & Staaf, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017911 · Cited by 418
Hanzlikova, H., Kalasova, I., Demin, A. A., Pennicott, L. E., Cihlarova, Z., & Caldecott, K. W. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.06.004 · Cited by 393
Chemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation
Gibson, B. A., Zhang, Y., Jiang, H., Hussey, K. M., Shrimp, J. H., Lin, H., Schwede, F., Yu, Y., & Kraus, W. L. (2016) · Science · doi:10.1126/science.aaf7865 · Cited by 367
Self-citationAre snoRNAs and snoRNA host genes new players in cancer?
Williams, G. T., & Farzaneh, F. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3195 · Cited by 362
Poly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Scott, C. L., Swisher, E. M., & Kaufmann, S. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8848 · Cited by 355
RNA helicase DDX21 coordinates transcription and ribosomal RNA processing
Calo, E., Flynn, R. A., Martin, L., Spitale, R. C., Chang, H. Y., & Wysocka, J. (2015) · Nature · doi:10.1038/nature13923 · Cited by 324
Gong, J., Li, Y., Liu, C.-J., Xiang, Y., Li, C., Ye, Y., Zhang, Z., Hawke, D. H., Park, P. K., Diao, L., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.070 · Cited by 249
Patterns of ribosomal protein expression specify normal and malignant human cells
Guimaraes, J. C., & Zavolan, M. (2016) · Genome Biology · doi:10.1186/s13059-016-1104-z · Cited by 240
Belin, S., Beghin, A., Solano-Gonzàlez, E., Bezin, L., Brunet-Manquat, S., Textoris, J., Prats, A.-C., Mertani, H. C., Dumontet, C., & Diaz, J.-J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007147 · Cited by 237
Jady, B. E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.541 · Cited by 222
PARP inhibitors: Clinical utility and possibilities of overcoming resistance
Bitler, B. G., Watson, Z. L., Wheeler, L. J., & Behbakht, K. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.10.003 · Cited by 217
Unifying cancer and normal RNA sequencing data from different sources
Wang, Q., Armenia, J., Zhang, C., Penson, A. V., Reznik, E., Zhang, L., Minet, T., Ochoa, A., Gross, B. E., Iacobuzio-Donahue, C. A., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.61 · Cited by 202
Sun, M., Gadad, S. S., Kim, D.-S., & Kraus, W. L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.023 · Cited by 189
Self-citationLocus-Specific Targeting to the X Chromosome Revealed by the RNA Interactome of CTCF
Kung, J. T., Kesner, B., An, J. Y., Ahn, J. Y., Cifuentes-Rojas, C., Colognori, D., Jeon, Y., Szanto, A., del Rosario, B. C., Pinter, S. F., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.006 · Cited by 167
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Weil, M. K., & Chen, A. P. (2011) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2010.12.002 · Cited by 162
Inheritance of Silent rDNA Chromatin Is Mediated by PARP1 via Noncoding RNA
Guetg, C., Scheifele, F., Rosenthal, F., Hottiger, M. O., & Santoro, R. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.024 · Cited by 154
New Facets in the Regulation of Gene Expression by ADP-Ribosylation and Poly(ADP-ribose) Polymerases
Ryu, K. W., Kim, D.-S., & Kraus, W. L. (2015) · Chemical Reviews · doi:10.1021/cr5004248 · Cited by 152
Self-citationLheureux, S., Lai, Z., Dougherty, B. A., Runswick, S. K., Hodgson, D., Timms, K. M., Lanchbury, J. S. S., Kaye, S. B., Gourley, C., Bowtell, D. D. L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2615 · Cited by 151
Wacker, D. A., Ruhl, D. D., Balagamwala, E. H., Hope, K. M., Zhang, T., & Kraus, W. L. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01314-07 · Cited by 141
Self-citationDomagała, P., Huzarski, T., Lubiński, J., Gugała, K., & Domagała, W. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1441-2 · Cited by 137
Parsels, L. A., Karnak, D. M., Parsels, J. D., Zhang, Q., Vélez-Padilla, J., Reichert, Z. R., Wahl, D. R., Maybaum, J., O’Connor, M. J., Lawrence, T. S., et al. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0455 · Cited by 137
Fischbach, A., Krüger, A., Hampp, S., Assmann, G. M., Rank, L., Hufnagel, M., Stöckl, M. T., Fischer, J. M. F., Veith, S., Rossatti, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1205 · Cited by 116
Generation and Characterization of Recombinant Antibody-like ADP-Ribose Binding Proteins
Gibson, B. A., Conrad, L. B., Huang, D., & Kraus, W. L. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00670 · Cited by 115
Self-citationLuo, X., Ryu, K. W., Kim, D.-S., Nandu, T. S., Medina, C. J., Gupte, R., Gibson, B. A., Soccio, R. E., Yu, Y., Gupta, R. K., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.11.015 · Cited by 111
Self-citationPoly(ADP-Ribose) Polymerase 1 (PARP-1) Regulates Ribosomal Biogenesis in Drosophila Nucleoli
Boamah, E. K., Kotova, E., Garabedian, M. V., Jarnik, M., & Tulin, A. V. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002442 · Cited by 109
PARP inhibitors in ovarian cancer: evidence, experience and clinical potential
Evans, T., & Matulonis, U. A. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016687254 · Cited by 109
Cimino, D., Fuso, L., Sfiligoi, C., Biglia, N., Ponzone, R., Maggiorotto, F., Russo, G., Cicatiello, L., Weisz, A., Taverna, D., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23660 · Cited by 95
Elevated DDX21 regulates c-Jun activity and rRNA processing in human breast cancers
Zhang, Y., Baysac, K., Yee, L.-F., Saporita, A. J., & Weber, J. D. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0449-z · Cited by 80
Purification of Ribosomes from Human Cell Lines
Belin, S., Hacot, S., Daudignon, L., Thérizols, G., Pourpe, S., Mertani, H. C., Rosa‐Calatrava, M., & Diaz, J. (2010) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0340s49 · Cited by 77
A Cell-Line-Specific Atlas of PARP-Mediated Protein Asp/Glu-ADP-Ribosylation in Breast Cancer
Zhen, Y., Zhang, Y., & Yu, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.106 · Cited by 69
c-Jun Supports Ribosomal RNA Processing and Nucleolar Localization of RNA Helicase DDX21
Holmström, T. H., Mialon, A., Kallio, M. J., Nymalm, Y., Mannermaa, L., Holm, T., Johansson, H. J., Black, E. J., Gillespie, D. A., Salminen, T. A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709613200 · Cited by 67
Melikishvili, M., Chariker, J. H., Rouchka, E. C., & Fondufe‐Mittendorf, Y. N. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.43 · Cited by 65
Huambachano, O., Herrera, F., Rancourt, A., & Satoh, M. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.175190 · Cited by 61
Inhibition of Human Dyskerin as a New Approach to Target Ribosome Biogenesis
Rocchi, L., Barbosa, A. J. M., Onofrillo, C., Río, A. D., & Montanaro, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101971 · Cited by 41
Identification and Characterization of Human snoRNA Core Promoters
Li, T., Zhou, X., Wang, X., Zhu, D., & Zhang, Y. (2010) · Genomics · doi:10.1016/j.ygeno.2010.03.010 · Cited by 23
Cited by
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
González-Martín, A., Pothuri, B., Vergote, I., DePont Christensen, R., Graybill, W., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P., Freyer, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910962 · Cited by 2,263
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Rose, M., Burgess, J. T., O’Byrne, K., Richard, D. J., & Bolderson, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564601 · Cited by 719
PARP and PARG inhibitors in cancer treatment
Slade, D. (2020) · Genes & Development · doi:10.1101/gad.334516.119 · Cited by 667
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
Kang, J., Brajanovski, N., Chan, K. T., Xuan, J., Pearson, R. B., & Sanij, E. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00728-8 · Cited by 408
Metadata
- Authors
- Kim, D.-S., Camacho, C. V., Nagari, A., Malladi, V. S., Challa, S., & Kraus, W. L.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2019-09
- Volume
- 75
- Issue
- 6
- Pages
- 1270-1285.e14
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2963279792
- Cited by
- 260
- References
- 63
- FWCI
- 12.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.